NAGS Antibody - C-terminal region
Artikelnummer:
ASB-ARP51183_T100
- Bilder (4)
| Artikelname: | NAGS Antibody - C-terminal region |
| Artikelnummer: | ASB-ARP51183_T100 |
| Hersteller Artikelnummer: | ARP51183_T100 |
| Alternativnummer: | ASB-ARP51183_T100-25UL,ASB-ARP51183_T100-100UL |
| Hersteller: | Aviva |
| Wirt: | Rabbit |
| Kategorie: | Proteine/Peptide |
| Applikation: | WB |
| Spezies Reaktivität: | Bovine, Canine, Equine, Guinea pig, Human, Mouse, Porcine, Rabbit, Rat, Zebrafish |
| Immunogen: | The immunogen is a synthetic peptide directed towards the C terminal region of human NAGS |
| Alternative Synonym: | AGAS, ARGA |
| NAGS is a mitochondrial enzyme that catalyzes the formation of N-acetylglutamate (NAG) from glutamate and acetyl coenzyme-A. NAG is a cofactor of carbamyl phosphate synthetase I (CPSI), the first enzyme of the urea cycle in mammals. Deficiencies in N-acetylglutamate synthase have been associated with hyperammonemia.The N-acetylglutamate synthase gene encodes a mitochondrial enzyme that catalyzes the formation of N-acetylglutamate (NAG) from glutamate and acetyl coenzyme-A. NAG is a cofactor of carbamyl phosphate synthetase I (CPSI), the first enzyme of the urea cycle in mammals. This gene may regulate ureagenesis by altering NAG availability and, thereby, CPSI activity. Deficiencies in N-acetylglutamate synthase have been associated with hyperammonemia. |
|
|
WB Suggested Anti-NAGS Antibody Titration: 1.25ug/ml Positive Control: HepG2 cell lysate |
|
|
Host: Rabbit Target: NAGS Positive control (+): HepG2 Cell Lysate (HG) Negative control (-): Human Ovary Tumor (T-OV) Antibody concentration: 1ug/ml |
|
|
25 ug of the indicated Human whole cell extracts was loaded onto a 12% SDS-PAGE gel. 1 ug/mL of the antibody was used in this experiment. The protein may be modified by acetylation. |
|
|
NAGS antibody - C-terminal region (ARP51183_T100) in Human HepG2 using Western Blot |
Produktgarantie und fachkundiger Support
